Market Tracker

05/25 6:50am ET

Biospecifics Technologies Corp (NASDAQ:BSTC)

35.98
Delayed Data
As of May 24
 +0.85 / +2.42%
Today’s Change
30.70
Today|||52-Week Range
72.07
-16.27%
Year-to-Date
New Strong Sell Stocks for May 13th
May 13 / Zacks.com - Paid Partner Content
BioDelivery (BDSI) Posts In-Line Loss in Q1, Revenues Miss
May 11 / Zacks.com - Paid Partner Content
Repros (RPRX) Q1 Loss Narrower Y/Y, Pipeline in Focus
May 11 / Zacks.com - Paid Partner Content
ARIAD (ARIA) Q1 Loss Narrower But Revenues Disappoint (Revised)
May 11 / Zacks.com - Paid Partner Content
Jazz (JAZZ) Tops Q1 Earnings, Raises Earnings Outlook
May 11 / Zacks.com - Paid Partner Content
 

Today’s Trading

Previous close35.13
Today’s open35.22
Day’s range35.06 - 36.35
Volume54,959
Average volume (3 months)65,635
Market cap$246.6M
Dividend yield--
Data as of 05/24/2016

Growth & Valuation

Earnings growth (last year)+100.00%
Earnings growth (this year)+6.06%
Earnings growth (next 5 years)+38.00%
Revenue growth (last year)+61.61%
P/E ratio25.9
Price/Sales13.74
Price/Book5.42

Competitors

 Today’s
change
Today’s
% change
FLXNFlexion Therapeutics...+0.94+8.87%
ENZEnzo Biochem Inc+0.17+2.76%
NVIVInVivo Therapeutics ...+0.33+5.09%
RGNXRegenxbio Inc-0.28-2.35%
Data as of 05/24/2016

Financials

Next reporting dateAugust 8, 2016
EPS forecast (this quarter)$0.46
Annual revenue (last year)$22.8M
Annual profit (last year)$9.6M
Net profit margin42.28%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, CEO, CFO, Director &
CAO
Thomas L. Wegman
Controller
James Goris
Corporate headquarters
Lynbrook, New York

Forecasts